AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 61 filers reported holding AVROBIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,064,000 | +7.1% | 793,712 | 0.0% | 0.10% | -25.4% |
Q3 2020 | $10,334,000 | -25.4% | 793,712 | 0.0% | 0.13% | -33.3% |
Q2 2020 | $13,850,000 | +34.2% | 793,712 | +19.7% | 0.20% | +12.7% |
Q1 2020 | $10,319,000 | -19.2% | 663,174 | +4.5% | 0.17% | -4.9% |
Q4 2019 | $12,777,000 | +58.6% | 634,700 | +11.2% | 0.18% | +19.0% |
Q3 2019 | $8,058,000 | +367.4% | 570,700 | +438.4% | 0.15% | +466.7% |
Q2 2019 | $1,724,000 | -60.6% | 106,000 | -46.6% | 0.03% | -60.3% |
Q1 2019 | $4,379,000 | +5.2% | 198,583 | -20.5% | 0.07% | -11.7% |
Q4 2018 | $4,161,000 | -67.9% | 249,900 | -0.0% | 0.08% | -50.6% |
Q3 2018 | $12,968,000 | +81.6% | 250,000 | 0.0% | 0.16% | +83.5% |
Q2 2018 | $7,140,000 | – | 250,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |